10.24873/j.rpemd.2024.12.1413

Original Research

 

Oral health-related quality of life and levels of anxiety and depression in individuals with oral potentially malignant disorders

Qualidade de vida relacionada à saúde bucal e níveis de ansiedade e depressão em indivíduos com desordens orais potencialmente malignas

 

Rhayane da Conceição Monteiro^1,* 0000-0003-4156-5289

Igor Ferreira Borba de Almeida¹ 0000-0002-8396-7385

Nataly Ferreira de Jesus Pinto¹ 0000-0002-5850-0732

Maria da Conceição Andrade¹ 0000-0001-7221-1163

Márcio Campos Oliveira¹ 0000-0002-1913-0417

¹ Universidade Estadual de Feira de Santana, Bahia, Brasil.

 

Article history:

Received 7 February 2024

Accepted 5 December 2024

Available online 20 December 2024

 

^*Correspondence to:

 

Abstract

Objectives: To evaluate oral health-related quality of life and possible correlations with anxiety and depression in patients with oral potentially malignant disorders.

Methods: This cross-sectional study was carried out in a reference center for oral lesions in the interior of the state of Bahia from February 2022 to January 2023, using the questionnaires Oral Health Impact Profile-14, Generalized Anxiety Disorder-7 and Patient Health Questionnaire-9.

Results: There was a slight change in the oral health-related quality of life of individuals in the sample, with a prevalence of responses to psychological discomfort, psychological incapacity, and physical pain domains. In addition, 39.7% and 17.9% of patients were identified as likely having generalized anxiety and depressive symptoms, respectively. When relating the levels of anxiety and depression with the perception of oral health-related quality of life, a positive correlation was found (p<0.0001).

Conclusions: Patients with oral potentially malignant disorders showed a slight change in oral health-related quality of life. However, there was a positive correlation between the perception of oral health-related quality of life and levels of anxiety and depression.

Keywords: Anxiety, Depression, Leukoplakia oral, Lichen planus oral, Quality of life

 

Resumo

Objetivos: Avaliar a qualidade de vida relacionada à saúde bucal e possíveis correlações com os estados de ansiedade e depressão em pacientes com desordens orais potencialmente malignas.

Métodos: Estudo transversal, realizado num centro de referência de lesões orais no interior da Bahia, no período de fevereiro de 2022 a janeiro de 2023, utilizando os questionários Oral Health Impact Profile–14, Generalized Anxiety Disorder-7 e Patient Health Questionnaire–9.

Resultados: Observou-se discreta alteração na qualidade de vida relacionada à saúde bucal dos indivíduos da amostra, havendo uma prevalência de resposta aos domínios desconforto psicológico, incapacidade psicológica e dor física. Além disso, 39,7% e 17,9% dos pacientes foram identificados como casos prováveis de ansiedade generalizada e com presença de sintomas depressivos, respectivamente. Quando relacionados os níveis de ansiedade e depressão com a perceção da qualidade de vida relacionada à saúde bucal, foi observada uma correlação positiva (p<0,0001).

Conclusões: Os pacientes com desordens orais potencialmente malignas apresentaram discreta alteração na qualidade de vida relacionada à saúde bucal. Contudo, verificou-se uma correlação positiva entre a perceção da qualidade de vida relacionada à saúde bucal e os níveis de ansiedade e depressão.

Palavras-chave: Ansiedade, Depressão, Leucoplasia oral, Líquen plano bucal, Qualidade de vida

 

Introduction

Oral potentially malignant disorders (OPMDs) are clinical manifestations defined as benign changes with areas of modified epithelium that present a high risk of transformation into oral cancer.¹ According to the literature, leukoplakia is the most common OPMD, with an estimated worldwide prevalence of 4.3% and an annual rate of malignant transformation of around 1.56%.^{2, 3}

Proliferative verrucous leukoplakia, a distinct condition, has a high risk of malignancy, with a rate of 9.3% per year, followed by erythroplakia, with a prevalence between 0.01% and 0.83% and an annual malignant transformation rate of 2.7%.^{2, 3} Clinical entities such as oral lichen planus, oral lichenoid lesions, and oral submucous fibrosis have an anual malignant transformation rate of 0.28%, 0.57%, and 0.98%, respectively. 3 In turn, there is no consensus on the malignant transformation rate of actinic cheilitis, with values such as 3.07% and 14%.^{4, 5}

Patients with OPMD may present significant health-related symptoms, such as pain, burning sensation, functional limitations, and psychosocial impairment, due to anxiety and the burden of a chronic disease with the potential for malignancy.^{6, 7} Recent studies indicate that these symptoms may negatively impact the oral health-related quality of life (OHRQoL) of individuals affected by such disorders.^{7, 10} Furthermore, research using psychological questionnaires in these patients found increased stress, anxiety, and depression levels when compared to the control group.^{11, 12} However, despite the rise in new cases of patients with OPMD in recent decades, the literature is scarce regarding the impact of oral problems on quality of life, anxiety, and depression in these individuals.¹³ OHRQoL assessment is based on the effect of oral conditions on patients’ daily activities, well-being, and quality of life.

Therefore, analyzing such outcomes allows the clinician to identify functional limitations, psychosocial aspects, and responsiveness to the management of oral symptoms and, thus, adapt treatment strategies aimed at comprehensive care and improving patients’ OHRQoL.¹⁴

Owing to the lack of specific questionnaires for assessing the OHRQoL of individuals with OPMD adapted to diferente sociocultural contexts,¹⁵ studies have used nonspecific questionnaires such as the Short Form Health Survey (SF-36) and the Oral Health Impact Profile Short Form (OHIP-14) as data collection instruments. Nevertheless, most of these studies have focused on assessing quality of life only in patients with oral lichen planus.^{16 - 19}

Given the social, epidemiological, and clinical relevance of the topic, the present study aimed to assess the OHRQoL and possible correlated anxiety and depression in patients with oral potentially malignant disorders.

Material and methods

This cross-sectional study was carried out from February¹, 2022, to January 31, 2023, at the Oral Injury Reference Center of the State University of Feira de Santana. It was part of a larger project and approved by the Human Research Ethics Committee of the State University of Feira de Santana, with CAAE: 46614221.3.0000.0053.

The present study is part of a larger methodological study based on the exploratory factor analysis of 20 patients for each item analyzed.²⁰ Thus, this study’s population was obtained using the non-probabilistic, consecutive serial sampling technique.

The inclusion criteria for this research were patients aged 18 years or older who had received a clinical diagnosis of OPMD by two examiners specialized in stomatology, with or without a histopathological diagnosis of mild, moderate, or severe epithelial dysplasia, and who, after reading the informed consent, agreed to participate in the research. On the other hand, we excluded patients with a clinical diagnosis of OPMD and a histopathological diagnosis of carcinoma in situ and patients with decompensated metabolic syndromes (diabetes mellitus, systemic arterial hypertension, autoimmune diseases, and any other disease).

The Oral Health Impact Profile-14 (OHIP-14), the Generalized Anxiety Disorder-7 (GAD-7), and the Patient Health Questionnaire-9 (PHQ-9) questionnaires were used to collect data, in their respective versions validated for Brazilian Portuguese.^{21 - 23}

The OHIP-14 was applied to assess individuals’ perception of the impact of oral dysfunctions on their quality of life, measuring how these dysfunctions affected their physical, psychological, and social well-being. This instrument is a reduced version of the Oral Health Impact Profile (OHIP) composed of 14 items grouped into 7 dimensions: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and disability in performing daily activities.²⁴ Patients responded to each alternative of the OHIP-14 according to the frequency of the events as “never”, “rarely”, “sometimes”, “repeatedly”, and “always”, structured on a Likert scale from 0 to 4, respectively. OHIP-14 was measured using the additive method, with the total score ranging from 0 to 56 and higher scores indicating a worse OHRQoL.²⁵

The GAD-7 instrument aims to screen for generalized anxiety. It consists of seven items structured on a four-point scale where 0 corresponds to “never,” 1 to “several days,” 2 to “more than half the days,” and 3 to “almost every day.” The total score can range from 0 to 21 points. The items assess the following aspects: feeling nervous, anxious, or on edge; being able to stop or control worrying; worrying too much about diferente things; difficulty relaxing; being restless; becoming easily upset or irritable; feeling afraid as if something terrible could happen.²⁶ In screening for anxiety disorders, a score of 8 represents a reasonable cutoff point to identify probable cases of generalized anxiety disorder. In this case, further diagnostic evaluation is necessary to determine the presence and type of anxiety disorder.^{27, 28}

The PHQ-9 assesses the presence of depressive symptoms in the last two weeks before the questionnaire application. The symptoms assessed consist of anhedonia; feeling depressed or without hope; sleep problems; tiredness or lack of energy; change in appetite; feelings of guilt or worthlessness; difficulty concentrating; feeling slow or restless; suicidal thoughts.²⁹

The nine items are assessed on a four-point scale where 0 corresponds to “never,” 1 to “several days,” 2 to “more than half the days,” and 3 to “almost every day,” resulting in a total score that can range from 0 to 27 points. For this instrument, based on the sum of the items, a cutoff point ≥ 10 presents better screening performance in detecting major depressive disorder.³⁰

Patients’ general information and clinical status were collected using a sociodemographic and clinical data assessment form containing the participant’s data; clinical data of the acute disease, including clinical diagnosis, histopathological characteristics, whether there were symptoms and treatment for the OPMD; and previous clinical data regarding lifestyle habits and oral hygiene.

Patients who were followed at the Oral Injury Reference Center for OPMD were screened regarding the inclusion and exclusion criteria by evaluating their clinical records. Then, patients who agreed to participate in the research signed the informed consent form.

The instruments were applied through interviews, in which participants verbally answered the alternatives in each questionnaire. The interviewers were previously trained to obtain the data. The information collected was recorded in a database generated on the REDCap platform.³¹

Because this research was developed during the COVID-19 pandemic, the prevailing biosafety measures recommended by the World Health Organization and the Ministry of Health were followed.

A descriptive analysis was performed to characterize the sample for statistical analysis. Categorical variables were described using absolute and relative frequencies, while numerical variables were presented as mean and standard deviation.

The relationship between the variables quality of life, depression, and anxiety was established using Pearson’s correlation coefficient with a 95% confidence interval. The qualitative assessment of the degree of correlation between the variables was based on the Callegari-Jacques classification.³² All analyses were performed using the statistical software GraphPad Prism version 9.0.3 (GraphPad Software, San Diego – CA, USA), and the significance level adopted was p<0.05.

Results

A total of 157 patients were interviewed, but one participant was excluded for not presenting all four instruments completed. The final sample had 156 patients, with a mean age of 55.3 (±14.17) years, ranging from 19 to 87 years. Table 1 describes the other sociodemographic and clinical data of the participants. The OHIP-14 presented a mean score of 10.24 (±10.10), which can be classified as a slight change in the OHRQoL in patients with OPMD. The OHIP-14 items were grouped into their respective domains and prioritized according to their impact on the patients’ quality of life, as shown in Figure 1. There was a predominance of psychological discomfort—“feeling uncomfortable” and “feeling stressed,” followed by psychological disability—“difficulty relaxing” and “feeling embarrassed,” and physical pain—“discomfort when eating” and “severe pain in the mouth.”

 

Table 1. Sociodemographic and clinical data of the study participants (n=156).

 

Figure 1. Level of response intensity according to the domains of OHIP-14.

 

Regarding GAD-7 and PHQ-9, their mean and standard deviation scores were 6.83 (±5.43) and 5.20 (±4.97), respectively. Based on the cutoff points adopted for each instrument, approximately 39.7% (n=62) of the interviewees were probable cases of generalized anxiety, and 17.9% (n=28) had depressive symptoms. Figure 2 shows the relationship between the total scores of OHIP-14, GAD-7, and PHQ-9, analyzed using Pearson’s correlation coefficient, in which a 95% confidence interval was adopted. A moderate positive correlation was identified between OHIP-14 and GAD-7 (R=0.5919) and between OHIP-14 and PHQ-9 (R=0.4425), with a p<0.0001 for both relationships (Table 2).

 

Figure 2. Correlation of the total scores of OHIP-14 with GAD-7 and PHQ-9, respectively.

 

Table 2. Correlation of the total scores of OHIP-14 with GAD-7 and PHQ-9, respectively.

 

Discussion

Understanding the sociodemographic and clinical profile of patients with OPMD in a given population is of the utmost importance for identifying associated risk factors, planning prevention strategies, and obtaining an early diagnosis³³ In the present study, there was a prevalence of males, with a mean age of 55.3 years, and more than half of the sample was over 50 years old; these findings are similar to those found in previous studies with Brazilian populations.^{34 - 37}

Regarding clinical diagnosis, the prevalence of actinic cheilitis stands out, representing 45.5% of the sample. Araújo et al.³⁴ state that this OPMD appears to be frequent in northeastern Brazil. Thus, the high prevalence found in the present study may derive from the location of the Reference Center in the interior of Bahia, a region under high levels of ultraviolet radiation.³⁸

Given the impact of oral problems on the patient’s general health and well-being, assessing OHRQoL has become useful for identifying at-risk populations and is essential for developing interventions aimed at comprehensive care.³⁹ Thus, this study aimed to evaluate the OHRQoL and possible correlated anxiety and depressive states in patients with OPMD, using the OHIP-14, GAD-7, and PHQ-9 questionnaires.

The results demonstrated a low impact of OPMD on the OHRQoL of this sample’s patients, given the average score of 10.24 on a scale of 0 to 56. However, this finding differs from a study conducted in Spain using the same collection instrument to assess the perception of OHRQoL in patients with oral lichen planus. Those authors identified a worse quality of life in patients with OPMD, with an average score of 28.01. When comparing the clinical form of oral lichen planus lesions, they found a worse quality of life associated with the group with ulcerative lesions than those with reticular presentation, with an average value of 28.84.17 In fact, evidence suggests that patients with erosive oral lichen planus present greater changes in OHRQoL, given the painful symptoms associated with its more severe clinical presentation that cause discomfort during meals and difficulty speaking, swallowing, and maintaining oral hygiene care.^{18, 19}

The prevalence of actinic cheilitis in the present study suggests that this disorder may be associated with discrete changes in the patient’s OHRQoL. The clinical presentation of this OPMD may explain this finding, since its initial characteristics include smooth, pale areas with dryness and fissures in the vermilion region of the lower lip. Given the slow development of the lesion,² the clinical changes are often not valued by the patient and, due to their anatomical location, are not directly associated with a commitment to oral health. Longitudinal studies are required to validate this association.

The percentage of individuals diagnosed with leukoplakia in this study may have also contributed to the discrete OHRQoL changes, since the clinical presentation of this disorder initially consists of a white or grayish plaque, usually flat, which may blend with the normal mucosa.² There are no reports of associated painful symptoms in most cases.³⁷ The presence of the lesion is usually imperceptible to the patient.

When evaluating the OHIP-14 domains, the results of this sample indicated a prevalence of psychological discomfort, followed by psychological disability and physical pain. These findings agree with the studies by Liu et al.⁴⁰ and Vilar-Villanueva et al.¹⁷ The presence of symptoms associated with the OPMD in some of the patients interviewed appeared to be related to their response to the psychological discomfort, psychological disability, and physical pain domains. In the presente study, no direct association was made between OPMD and its symptoms and the prevalence of these domains. However, a study carried out on the impact of stomatological diseases on OHRQoL demonstrated that patients with symptoms related to the sensation of dry mouth, pain or burning in the mouth or tongue, and the presence of ulcers presented a worse OHRQoL in terms of psychological discomfort, physical pain, and functional limitations.⁴¹

Among questionnaires aimed at measuring OHRQoL, the OHIP-14 is an instrument validated for the Brazilian contexto used in clinical research.^{21, 42} However, given the diferences found, the results of this study reinforce the need for a specific quality of life questionnaire for patients with OPMDs adapted to different contexts,⁸ such as Brazil.¹⁵

Furthermore, due to OHIP-14’s subjective nature, Alvarenga et al.⁴³ suggested that factors such as the patient’s personality profile and sociodemographic aspects, like housing situation, marital status, and education level, could interfere with the perception of oral health status and, consequently, with the results of studies using this model. In this sense, given the discrete OHRQoL changes in the patients in this sample, future studies should compare OHRQoL questionnaires with the clinical condition and sociodemographic variables in patients with OPMD.

According to the literature, patients with erosive oral lichen planus suffer anxiety and depression, which negatively impact their quality of life.¹⁶ Rana et al.,⁴⁴ when comparing the quality of life among patients with OPMD, oral cancer, and cancer recurrence, observed that although patients with OPMD reported less impact on their quality of life, they reported higher rates concerning mood and anxiety due to the possibility of changes in the mucosa.

When analyzing the presence of psychological disorders, this study’s results showed that 39.7% and 17.9% of the sample may present generalized anxiety and depressive symptoms, respectively. These findings corroborate a qualitative study conducted in India, in which patients with OPMD reported feelings of frustration and depression because of their oral condition and the impairment of their psychological well-being.⁸

Vilar-Villanueva et al.¹⁷ identified that patients with oral lichen planus had higher scores compatible with anxiety and depression than the control group. Unlike the present study, they found a higher percentage of patients with depressive symptoms (64.6%) than with anxiety (35.4%).¹⁷

Psychosocial impairment in individuals with OPMD may be mainly associated with the possibility of malignant transformation and how coping with the disease may interfere with daily activities, well-being, and social interaction. Furthermore, the presence of painful symptoms concomitante with the diagnosis in younger patients seems to contribute to more anxiety symptoms than in older individuals.⁴⁵

However, the present study identified a higher percentage of probable cases of anxiety in a sample mostly composed of middle-aged individuals. The identification of possible cases of anxiety and depression in this population is essential when considering the patient’s perspectives during decision-making.⁸ Recognizing the presence and severity of psychological distress associated with managing chronic diseases and appropriately treating it contribute to a marked improvement in quality of life.⁴⁶ Suggesting associated psychological treatment can also be beneficial in monitoring patients with OPMD.^{16, 17, 47} Given the possible cases of anxiety and depression in this sample, we sought to check for a relationship between psychoemotional disorders and OHRQoL perception in these individuals.

The results demonstrated a statistically significant moderate positive correlation between the total scores of OHIP-14, GAD-7, and PHQ-9. A similar finding was reported by Yang et al., ⁴⁸ who related the OHIP-14 with the Hospital Anxiety and Depression Scale (HADS) in patients with oral lichen planus, and observed that OHRQoL was positively correlated with anxiety (r = 0.449; p = 0.000) and depression (r = 0.500; p = 0.000). On the other hand, Vilar-Villanueva et al.¹⁷ identified no statistical significance between HADS and OHIP-14. Nonetheless, they found that the presence of psychological disorders was associated with higher scores in psychological discomfort, psychological disability, and physical pain domains of the OHIP-14.¹⁷ Assessing OHRQoL can be challenging due to its latent concept.

However, understanding such aspects allows health professionals and services to view the patient as an individual inserted into unique life contexts with different perceptions of health. Thus, they can develop personalized treatment plans that are not exclusively curative but also promote health.⁴²

Similar to the limitations found by Ashshi et al.,⁴⁹ the cross-sectional design of the present study does not allow determining the causality of the discrete changes in OHRQoL and the presence of anxiety and depression in these patients. Furthermore, the sample size may have been affected by the pandemic period,⁴⁹ when part of the population felt apprehensive about attending dental services due to the possibility of contamination with COVID-19.

Moreover, these results only represent the condition of individuals treated at a single dental service and cannot be generalized to all patients with OPMD in Brazil and other sociocultural contexts. Nevertheless, the present study reinforces the importance of assessing OHRQoL in this population to promote individualized approaches for each case, as well as the need for referrals and the establishment of public health policies.

Finally, it is crucial to emphasize the need for future research on the correlation between anxiety, depression, and dysplasia severity in OPMD patients. The objective of this assessment is to better understand the psychological impairment associated with the progression of dysplasia, which can aid in developing more comprehensive therapeutic interventions.

Clinically, this investigation may help in the early identification of high-risk patients, allowing a multidisciplinar approach that includes the appropriate management of psychological aspects alongside clinical dysplasia treatment.

Conclusions

This study concludes that, according to the mean OHIP-14 value obtained, a slight change was observed in the OHRQoL of the patients in this sample, with a prevalence of psychological discomfort, psychological disability, and physical pain domains.

Concerning the presence of psychological disorders in patients with OPMD, possible cases of generalized anxiety and the presence of depressive symptoms were identified, besides a significant positive correlation between the perceived OHRQoL and the levels of anxiety and depression. Therefore, these results support future studies to evaluate the quality of life in patients with OPMD in different sociocultural contexts and reinforce the need for multidisciplinary care in monitoring these individuals, to improve psychological and social well-being.

 

References

¹. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from na international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862-80.

². Neville WB, Damm DD, Allen CM, Chi AC. Patologia Oral e Maxilofacial. 4.ª ed. Rio de Janeiro: Elsevier Brasil. 2016;1810p.

³. Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and metaanalysis of malignant transformation rate by subtype. Head Neck. 2020;42:539-55.

⁴. Dancyger A, Heard V, Huang B, Suley C, Tang D, Ariyawardana A. Malignant transformation of actinic cheilitis: A systematic review of observational studies. J Investig Clin Dent. 2018;9:e12343.

⁵. Carneiro MC, Quenta-Huayhua MG, Peralta-Mamani M, Honório HM, Santos PSDS, Rubira-Bullen IRF, et al. Clinicopathological Analysis of Actinic Cheilitis: A Systematic Review with Meta-analyses. Head Neck Pathol. 2023;17:708-21.

⁶. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010;46:423-5.

⁷. Gondivkar SM, Bhowate RR, Gadbail AR, Gaikwad RN, Gondivkar RS, Sarode SC, et al. Development and validation of oral health-related quality of life measure in oral submucous fibrosis. Oral Dis. 2018;24:1020-8.

⁸. Tadakamadla J, Kumar S, Lalloo R, Johnson NW. Qualitative analysis of the impact of Oral Potentially Malignant Disorders on daily life activities. PLoS One. 2017;12:e0175531.

⁹. Tadakamadla J, Kumar S, Lalloo R, Babu DBG, Johnson NW. Impact of oral potentially malignant disorders on quality of life. J Oral Pathol Med. 2018;47:60-5.

¹⁰. Patil SR, Yadav N, Al-Zoubi IA, Maragathavalli G, Sghaireen MG, Gudipaneni R, et al. Comparative study of the efficacy of newer antioxidants lycopene and oxitard in the treatment of oral submucous fibrosis. Pesqui Bras Odontopediatria Clíni Integr. 2018;18(1), 4059.

¹¹. Rojo-Moreno JL, Bagán JV, Rojo-Moreno J, Donat JS, Milián MA, Jiménez Y. Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:687-91.

¹². Chaudhary S. Psychosocial stressors in oral lichen planus. Aust Dent J. 2004;49:192-5.

¹³. Gondivkar SM, Gadbail AR, Gondivkar RS, Sarode SC, Sarode GS, Patil S. Impact of oral potentially malignant disorders on quality of life: a systematic review. Future Oncol. 2018;14:995-1010.

¹⁴. Bonecker M, Abanto J. Como as pesquisas de excelência em qualidade de vida relacionada à saúde bucal podem contribuir para a prática clínica? Rev Assoc Paul Cir Dent. 2014;68:220-2.

¹⁵. Almeida IFB, Freitas KS, Almeida DB, Lisboa LJ, Oliveira MC. Instrumentos de avaliação da qualidade de vida em indivíduos com desordens orais potencialmente malignas: revisão integrativa da literatura. Revista da Faculdade de Odontologia da Universidade Federal da Bahia. 2021;50(3).

¹⁶. Alves MG, Carvalho BFC, Balducci I, Cabral LA, Nicodemo D, Almeida JD. Emotional assessment of patients with oral lichen planus. Int J Dermatol. 2015;54:29-32.

¹⁷. Vilar-Villanueva M, Gándara-Vila P, Blanco-Aguilera E, Otero-Rey EM, Rodríguez-Lado L, García-García A, et al. Psychological disorders and quality of life in oral lichen planus patients and a control group. Oral Dis. 2019;25:1645-51.

¹⁸. Daume L, Kreis C, Bohner L, Kleinheinz J, Jung S. Does the Clinical Form of Oral Lichen Planus (OLP) Influence the Oral Health-Related Quality of Life (OHRQoL)? Int J Environ Res Public Health. 2020;17:6633.

¹⁹. Parlatescu I, Tovaru M, Nicolae CL, Sfeatcu R, Didilescu AC. Oral health-related quality of life in different clinical forms of oral lichen planus. Clin Oral Investig. 2020;24:301-8.

²⁰. Costello AB, Osborne J. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval. 2005;10:1-10.

²¹. Oliveira BH, Nadanovsky P. Psychometric properties of the Brazilian version of the Oral Health Impact Profile-short form. Community Dent Oral Epidemiol. 2005;33:307-14.

²². Mapi Research Institute. Certificate of linguistic validation certificate: general anxiety disorder-7 (GAD-7). Lyon, FR: Mapi Research Institute, 2006.

²³. Osório FL, Mendes AV, Crippa JA, Loureiro SR. Study of the discriminative validity of the PHQ-9 and PHQ-2 in a sample of Brazilian women in the context of primary health care. Perspect Psychiatr Care. 2009;45:216-27.

²⁴. Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997;25:284-90.

²⁵. Robinson PG, Gibson B, Khan FA, Birnbaum W. Validity of two oral health-related quality of life measures. Community Dent Oral Epidemiol. 2003;31:90-9.

. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-7.

²⁶.

²⁷Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317-25.

²⁸. Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24-31.

²⁹. Santos IS, Tavares BF, Munhoz TN, Almeida LSP, Silva NTB, Tams BD, et al. Sensibilidade e especificidade do Patient Health Questionnaire-9 (PHQ-9) entre adultos da população geral. Cad Saúde Pública. 2013;29:1533–43.

³⁰. Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37:67-75.

³¹. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadatadriven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-81.

³². Callegari-Jacques SM. Bioestatística [recurso eletrônico]: princípios e aplicações. Porto Alegre: Artmed Editora; 2007. 255p.

³³. Pires FR, Barreto ME, Nunes JG, Carneiro NS, Azevedo AB, Dos Santos TC. Oral potentially malignant disorders: clinicalrev pathological study of 684 cases diagnosed in a Brazilian population. Med Oral Patol Oral Cir Bucal. 2020;25:e84-8.

³⁴. Araújo CP, Vidal MTA, Gurgel CAS, Ramos EAG, Junior AAB, Ramalho LMP, et al. Queilite actínica: um estudo de 35 casos com destaque para os aspectos morfológicos. RPG, Rev Pós-Grad. 2012;19:21-7.

³⁵. Arnaud RR, Soares MSM, Paiva MAF, Figueiredo CRLV, Santos MGC, Lira CC. Queilite actínica: avaliação histopatológica de 44 casos. Rev Odontol UNESP. 2014;43:384-9.

³⁶. Mello FW, Melo G, Meurer MI, Rivero ERC. Intraoral Potentially Malignant Disorders in a Brazilian Oral Pathology Service: Epidemiological, Clinical, and Histopathological Findings. J Oncol. 2018;2018:2325808.

³⁷. Dogenski LC, Ribeiro SF, Gambin DJ, Maso PC, Linden MSS, Trentin MS, et al. Oral leukoplakia-epidemiological survey and histochemical analysis of 107 cases in Brazil. Clin Oral Investig. 2021;25:1859-67.

³⁸. Centro de Previsão de Tempo e Estudos Climáticos (CPTEC). Situação mais recente do Índice Ultravioleta para o Brasil. Instituto Nacional de Pesquisas Espaciais. 2023.

³⁹. Sischo L, Broder HL. Oral health-related quality of life: what, why, how, and future implications. J Dent Res. 2011;90:1264-70.

⁴⁰. Liu LJ, Xiao W, He QB, Jiang WW. Generic and oral quality of life is affected by oral mucosal diseases. BMC Oral Health.2012;12:2.

⁴¹. Llewellyn CD, Warnakulasuriya S. The impact ofstomatological disease on oral health-related quality of life. Eur J Oral Sci. 2003;111:297-304.

⁴². Campos LA, Peltomäki T, Marôco J, Campos JADB. Use of Oral Health Impact Profile-14 (OHIP-14) in Different Contexts. What Is Being Measured? Int J Environ Res Public Health. 2021;18:13412.

⁴³. Alvarenga FAS, Henriques C, Takatsui F, Montandon AAB, Júnior RT, Monteiro ALCC. Impacto da saúde bucal na qualidade de vida de pacientes maiores de 50 anos de duas instituições públicas do município de Araraquara-SP. Rev Odontol UNESP. 2011;40:118-24.

⁴⁴. Rana M, Gellrich NC, Rana M. Comparison of health-related quality of life of patients with different precancer and oral cancer stages. Clin Oral Investig. 2015;19:481-8.

⁴⁵. Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, et al. Validation of the HADS and PSS-10 and psychological status in patients with oral lichen planus. Oral Dis. 2020;26:96-110.

⁴⁶. Keles H, Ekici A, Ekici M, Bulcun E, Altinkaya V. Effect of chronic diseases and associated psychological distress on health-related quality of life. Intern Med J. 2007;37:6-11.

⁴⁷. Jalenques I, Lauron S, Almon S, Pereira B, D’Incan M, Rondepierre F. Prevalence and Odds of Signs of Depression and Anxiety in Patients with Lichen Planus: Systematic Review and Meta-analyses. Acta Derm Venereol. 2020;100:adv00330.

⁴⁸. Yang C, Liu L, Shi H, Zhang Y. Psychological problems and quality of life of patients with oral mucosal diseases: a preliminary study in Chinese population. BMC Oral Health. 2018;18:226.

⁴⁹. Ashshi RA, Stanbouly D, Maisano PG, Alaraik AF, Chuang SK, Takako TI, et al. Quality of life in patients with oral potentially malignant disorders: oral lichen planus and oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;135:363-71.

 

^*Corresponding author:

Rhayane da Conceição Monteiro

E-mail address: rhayane.monteiro@hotmail.com

 

Conflict of interest

The authors have no conflicts of interest to declare.

 

Ethical disclosures

Protection of human and animal subjects. TThe authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).

Confidentiality of data. The authors declare that they have followed their work center protocols on access to patient data and for its publication.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

 

CRediT authorship contribution statement

Rhayane da Conceição Monteiro: Conceptualization; Data curation, Formal analysis, Validation, Visualization, Writing – original draft, Writing – review & editing. Igor Ferreira Borba de Almeida: Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – review & editing. Nataly Ferreira de Jesus Pinto: Visualization, Writing – original draft, Writing – review & editing. Maria da Conceição Andrade: Conceptualization, Visualization, Writing – review & editing. Márcio Campos Oliveira: Conceptualization, Methodology, Data curation, Formal analysis, Validation, Visualization, Writing – original draft, Writing – review & editing.

 

Acknowledgments

We would like to thank all the patients for their voluntary participation, and the State University of Feira de Santana, the Pro-Rectorate of Research and Graduate Studies, the Oral Cancer Center, and the Oral Injury Reference Center of the State University of Feira de Santana for their support in conducting this research.

 

1646-2890/© 2024 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Published by SPEMD.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).